Benefits of Precision Painkillers
The development of so-called precision painkillers could transform the lives of millions of people with chronic pain. Professor Trent Munro from the Australian Institute for Bioengineering and Nanotechnology (AIBN) explains the status of the development of such medicines and the advantages they bring with them.
According to the medic, a spin-off company works the University of Queensland (UQ) is currently working on developing precision painkillers that work more precisely and are less harmful to the liver. Significant progress has evidently already been made.
Fewer side effects in pain management
“This type of targeted therapy reduces the potential side effects and safety issues associated with current pain treatments and also means fewer doses are required“, explained Professor Munro the benefits of precision painkillers.
Such medicines could be used to treat debilitating and chronic pain conditions are used, which for example Cancer, sciaticapost-herpetic neuralgia, peripheral nerve injuries and osteoarthritis, Munro said in one press release the University of Queensland.
Neuropathic pain is widespread
Currently, according to the expert up to ten percent of the adult population affected by neuropathic pain and many sufferers have it problems with treatment.
Because the drugs available to date often do not have the desired effect and they also carry a considerable risk of side effects, which also includes the risk of dependence, explains Munro. The new precision painkillers could make significant improvements possible for millions of people worldwide.
New drug could prevent liver toxicity
the current approach from Cassowary Pharma, the spin-off from the University of Queensland, is based on a molecule that experts believe plays an important role in the human body’s perception of pain, according to Professor Munro.
In the next 18 months it is planned to Recruit participants for clinical trials, in order to then further promote the market launch of the drug. Such a drug can work very precisely and thus also the liver toxicity impede. At the same time, it could Reduce overall drug exposureProfessor Munro hopes.
“I am always happy about the recognition of innovative research achievements from the institutes, faculties and schools of the UQ, which are reflected in practice“, added dr Dean Moss of the University of Queensland. (as)
Author and source information
This text corresponds to the requirements of medical specialist literature, medical guidelines and current studies and has been checked by medical professionals.
Sources:
- University of Queensland: UQ company starts revolution in chronic pain management (published 04.11.2022), University of Queensland
Important NOTE:
This article contains general advice only and should not be used for self-diagnosis or treatment. He can not substitute a visit at the doctor.